PIK3CA and breast cancer: High COX-2 expression is significantly correlated with better OS of PIK3CA wild-type and mutated patients in the TCGA cohort but this result was not observed in our BC cohort with a longer median follow-up delay (8.6 years for the Curie cohort versus 28.9 months for the TCGA cohort).